• Published on: Apr 06, 2020
  • 2 minute read
  • By: Dr Rajan Choudhary

MicroRNA That Makes Them Fight COVID Better ?

  • WhatsApp share link icon
  • copy & share link icon
  • twitter share link icon
  • facebook share link icon

Recently you may have read a New Delhi based International Center for Genetic Engineering and Biotechnology (ICGEB) sequenced the genome (genetic data) of SARS-COV-2 (coronavirus) from India, Italy, US, Nepal and Wuhan, China. They found that the Indian variant of SARS-CoV2 has the potential to be targeted by antiviral RNA within host cells, a feature that is unique to the Indian strain.

This amazing finding has been published on blogs, newspapers and other media as proof that Indians may not suffer as much as the rest of the world when the COVID-19 pandemic hits the country. One headline touted “MicroRNA in Indians may reduce severity of corona attack”, stating “Indians have comparatively better immunity compared to other countries”. Of course this article is being forwarded on WhatsApp, and enough people may take it as gospel. Is it true?

No.

If you want to know why, just look on the Journal’s website:

“these are preliminary reports that have not been peer-reviewed. They should NOT be regarded as conclusive, guide clinical practice/health-related behaviour, or be reported in news media as established information.”

Research is not easy. I could write a very long explanation for why, but I have summarised it below.

SUMMARY:

- To prove x causes y up to a high scientific standard is incredibly difficult

- Even if you think x causes y, someone might find a flaw in your study

- Numbers can be manipulated by statistics to show what you want to believe

- Reporters might not understand the study and mis-report it

- We all want to believe there is a magic cure that will protect us, that makes us special, immune to this disaster so we can get on with our lives. Unfortunately there simply isn’t one. And believing in them without fact checking can cause more harm than good.

IMMUNITY AGAINST COVID

So what about this study? Firstly it is looking at one tiny mechanism in a cell, when a cell can have millions of proteins responsible for a billion different functions in just the cell itself. Secondly it is not peer reviewed. This means no one has fact checked the study to check whether the design is valid, whether the statistics hold up, whether they have missed something or are making incorrect conclusions based off their data. Peer-reviewing a recent paper showing SARS-CoV-2 and HIV were extremely similar disproved this paper as false.

In the authors defence he acknowledges this:

“In our study, which is a purely computational one, we predicted that this microRNA binds to the SARS-Cov2 genome submitted from India. However, it is too early to comment on it because there is only one high coverage sequence from India, so far,”

Thirdly, the news article says that Indians have better immunity because of this “microRNA”. This is wrong. The study sequenced the genome of the virus, not of the Indian population. Antiviral microRNA is found in all people. The study simply suggests that this might be more effective at targeting the Indian strain of COVID, but it does not make any concrete claims that Indians are protected from COVID.

Again, the journal even states this:

“These are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information.”

But most importantly, even if the paper suggests that the Indian strain may be less potent, it does not give us an excuse to be reckless. We have to adhere to social distancing, hygiene, lockdown principles in order to prevent infection. Because what happens if you take the article stating “Indians have comparatively better immunity compared to other countries” as fact, use this as an excuse to go about your regular daily lives, and it actually turns out that the microRNA has little to no effect on COVID. This endangers yourself and those around you.

Be sensible. Listen to public health officials.

Dr Rajan Choudhary, UK, Chief Product Officer, Second Medic Inc

www.secondmedic.com

Read Blog
Tuberculosis

Tuberculosis Symptoms and Treatment: Early Signs, Diagnosis, and Recovery

Tuberculosis (TB) is one of the oldest known infectious diseases and continues to be a major public health concern, especially in developing countries. India accounts for a significant proportion of global TB cases, despite advances in diagnosis and treatment. The good news is that tuberculosis is preventable, treatable and curable when detected early and managed properly.

Understanding tuberculosis symptoms and treatment is critical for reducing disease spread, preventing complications and achieving complete recovery.

 

What Is Tuberculosis?

Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis. It primarily affects the lungs (pulmonary TB) but can also involve other parts of the body such as:

  • lymph nodes
     

  • bones and joints
     

  • kidneys
     

  • brain
     

TB spreads through the air when an infected person coughs, sneezes or speaks.

 

Why Tuberculosis Remains a Major Health Issue

According to the World Health Organization and ICMR data:

  • millions of new TB cases are reported annually
     

  • delayed diagnosis increases transmission
     

  • incomplete treatment leads to drug resistance
     

Early detection and treatment are key to TB control.

 

Common Tuberculosis Symptoms

TB symptoms often develop gradually and may be mild in the early stages, leading to delayed diagnosis.

Persistent Cough

A cough lasting more than two to three weeks is a hallmark symptom of pulmonary TB.

The cough may:

  • be dry or productive
     

  • worsen over time
     

  • sometimes produce blood
     

 

Fever and Night Sweats

Low-grade fever, especially in the evenings, is common.

Night sweats that soak clothing or bedding are a classic TB sign.

 

Unexplained Weight Loss

TB increases metabolic demand and reduces appetite, leading to significant weight loss.

 

Fatigue and Weakness

Persistent tiredness and reduced stamina occur due to chronic infection.

 

Chest Pain

Chest discomfort or pain may occur during coughing or breathing.

 

Symptoms of Extra-Pulmonary TB

When TB affects organs outside the lungs, symptoms depend on the site involved and may include:

  • swollen lymph nodes
     

  • bone or joint pain
     

  • headaches or neurological symptoms
     

  • urinary issues
     

 

Why TB Symptoms Are Often Ignored

Many TB symptoms resemble common infections or general weakness.

This leads to:

  • delayed medical consultation
     

  • prolonged transmission
     

  • disease progression
     

Awareness improves early detection.

 

How Tuberculosis Is Diagnosed

Diagnosis involves a combination of:

  • sputum tests
     

  • chest X-ray
     

  • molecular tests such as CBNAAT
     

  • blood tests and imaging for extra-pulmonary TB
     

Early and accurate diagnosis is essential for effective treatment.

 

Tuberculosis Treatment Explained

TB treatment involves a combination of antibiotics taken over a fixed duration.

Standard TB Treatment

For drug-sensitive TB, treatment typically lasts:

  • 6 months
     

The regimen includes multiple antibiotics taken in phases to ensure complete bacterial clearance.

 

Importance of Treatment Adherence

TB bacteria are slow-growing and resilient.

Stopping treatment early can result in:

  • incomplete cure
     

  • relapse
     

  • drug-resistant TB
     

Completing the full course is essential.

 

Drug-Resistant TB

If TB bacteria become resistant to standard drugs, treatment becomes longer and more complex.

Drug-resistant TB requires:

  • specialised medications
     

  • longer treatment duration
     

  • close medical supervision
     

Prevention of resistance depends on correct treatment from the start.

 

Side Effects of TB Treatment

Some individuals may experience side effects such as:

  • nausea
     

  • loss of appetite
     

  • mild liver enzyme changes
     

Most side effects are manageable with medical guidance and do not require stopping treatment.

 

TB and Public Health

TB is not just an individual health issue but a community concern.

Effective TB control requires:

  • early diagnosis
     

  • treatment adherence
     

  • contact tracing
     

  • public awareness
     

India’s national TB elimination programmes focus on these strategies.

 

Preventing Tuberculosis

Preventive measures include:

  • early detection and treatment of active TB
     

  • improving nutrition and immunity
     

  • adequate ventilation in living spaces
     

  • screening close contacts
     

BCG vaccination offers partial protection, especially in children.

 

Living With and Recovering From TB

With proper treatment:

  • symptoms gradually improve
     

  • infection becomes non-contagious
     

  • normal life can be resumed
     

Regular follow-up ensures complete recovery.

 

When to Seek Medical Help

Consult a healthcare provider if experiencing:

  • cough lasting more than two weeks
     

  • unexplained weight loss
     

  • persistent fever or night sweats
     

  • blood in sputum
     

Early action saves lives and prevents spread.

 

Long-Term Outlook After TB Treatment

Most individuals who complete treatment:

  • recover fully
     

  • regain normal lung function
     

  • return to daily activities
     

Long-term complications are rare with timely care.

 

Conclusion

Tuberculosis symptoms and treatment must be understood clearly to combat this preventable and curable disease. Persistent cough, fever, night sweats and weight loss should never be ignored. Early diagnosis, complete treatment adherence and regular follow-up are essential for curing TB and preventing transmission. With proper medical care and public awareness, tuberculosis can be effectively controlled and eliminated as a public health threat.


 

References

  • Indian Council of Medical Research (ICMR) – Tuberculosis Epidemiology and Treatment Guidelines
  • World Health Organization (WHO) – Global Tuberculosis Report
  • National Tuberculosis Elimination Programme (NTEP) – Government of India
  • Lancet Infectious Diseases – TB Diagnosis and Treatment Outcomes
  • National Family Health Survey (NFHS-5) – Infectious Disease Indicators
  • Statista – Global Tuberculosis Burden and Trends

See all

Live Doctor consultation
Live Doctor Chat

Download Our App & Get Consultation from anywhere.

App Download
call icon for mobile number calling and whatsapp at secondmedic